MetaCap

Baxter International Quarterly Income Statement

NYSE: BAXHealth CareMedical/Dental InstrumentsUSD

24.35+0.45 (+1.88%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Baxter International revenue and earnings

In the quarter ended Jun 30, 2026, Baxter International generated $2.96 billion in revenue, up 5.3% from the same quarter a year earlier. Net income was $126.0 million (+38.5% year over year), for a net margin of 4.3% versus a median of -0.6% in the prior 5 quarters. Gross margin was 34.9% (down from 35.3%) and operating margin 7.3%.

Diluted earnings per share came in at $0.24, up from $0.18.

Summary generated from market data by MetaCap's automated system. Methodology

Baxter International income statement (quarterly)

Baxter International quarterly income statement
Quarter (USD)Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31Q3 20232023-09-30
Revenue2.96B2.70B2.97B2.83B2.81B2.63B2.75B2.70B2.69B2.49B2.73B2.60B
Revenue growth (YoY)+5.34%+2.90%+8.03%+5.04%+4.31%+5.42%+0.88%+3.85%+3.98%+2.01%-27.13%-27.99%
Cost of Revenue1.93B1.81B2.40B1.89B1.82B1.76B1.79B1.67B1.66B1.53B1.63B1.54B
Gross Profit1.03B891.00M577.00M950.00M991.00M861.00M959.00M1.03B1.03B961.00M1.10B1.06B
Operating Expenses815.00M825.00M1.31B778.00M800.00M803.00M1.39B878.00M852.00M846.00M796.00M877.00M
Research & Development129.00M139.00M126.00M118.00M134.00M140.00M211.00M129.00M130.00M120.00M127.00M133.00M
Selling, General & Admin735.00M728.00M761.00M708.00M718.00M703.00M761.00M754.00M723.00M729.00M683.00M744.00M
Operating Income217.00M66.00M-729.00M172.00M191.00M58.00M-435.00M155.00M179.00M115.00M304.00M179.00M
Interest Expense-13.00M-12.00M—-10.00M-14.00M-17.00M—-14.00M104.00M103.00M113.00M136.00M
Other Income (Expense)5.00M-6.00M31.00M7.00M03.00M4.00M1.00M24.00M9.00M-11.00M12.00M
Pretax Income158.00M-6.00M-756.00M121.00M133.00M-3.00M-521.00M69.00M117.00M46.00M221.00M64.00M
Income Tax23.00M11.00M279.00M172.00M11.00M-67.00M-33.00M8.00M22.00M40.00M2.00M27.00M
Net Income126.00M-15.00M-1.13B-46.00M91.00M126.00M-512.00M140.00M-314.00M37.00M245.00M2.51B
Net Income growth (YoY)+38.46%-111.90%—-132.86%—+240.54%-308.98%-94.42%—-15.91%+35.36%—
EPS (Basic)0.24-0.03-2.21-0.090.180.25-1.000.27-0.620.070.484.95
EPS (Diluted)0.24-0.03-2.21-0.090.180.25-1.000.27-0.610.070.484.93
Shares Outstanding (Basic)517.00M515.00M—514.00M513.00M512.00M—510.00M510.00M508.00M—507.00M
Shares Outstanding (Diluted)518.00M515.00M—514.00M514.00M514.00M—512.00M511.00M510.00M—509.00M
EBITDA456.00M303.00M-489.00M409.00M448.00M305.00M-190.00M409.00M406.00M386.00M568.00M271.00M
Gross Margin34.86%32.99%19.40%33.51%35.27%32.80%34.83%38.27%38.27%38.59%40.31%40.63%
Operating Margin7.33%2.44%-24.51%6.07%6.80%2.21%-15.80%5.74%6.64%4.62%11.14%6.89%
Net Margin4.26%-56.00%-37.93%-1.62%3.24%4.80%-18.60%5.19%-11.66%149.00%8.98%96.50%

This table shows 12 quarterly periods of Baxter International's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow BAX's reporting calendar. What is a income statement?

More financial data